Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
First Digital Vaccine Card Service VaxYes Converts 10,000 COVID Vaccine Cards Into Digital Vaccine Certificates
GoGetVax, the country’s first end-to-end COVID-19 vaccine technology platform, has successfully helped its first 10,000 users […]
Caption Health Announces Steve Cashman as New President and CEO
Caption Health, a leading medical artificial intelligence (AI) company driving better health outcomes by increasing […]
Empatica’s EmbracePlus Wins CE Mark for Quality Physiological Data Collection
EmbracePlus by Empatica has received the European CE mark as a Class lla medical device, […]
Next Phase of Vaccine Roll-Out
The UK is moving into the next phase of the COVID-19 vaccine programme as the […]
LARVOL Launches Cancer-Focused Social Listening Platform
LARVOL, leading provider of data and intelligence solutions for the pharmaceutical and biotech industry, today […]
Axa Collaborates with Microsoft to Create the next Generation Standard of Health and Well-being Services
AXA announced it is collaborating with Microsoft to build a digital healthcare platform, enabling a […]
Diogo Rau to Join Lilly as Senior Vice-president and Chief Information and Digital Officer
Eli Lilly and Company announced today that Diogo Rau will join the company on May 17, 2021 as senior vice-president […]
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer
Today, the U.S. Food and Drug Administration (FDA) authorized marketing of the GI Genius, the […]
KD Pharma Group Acquires Phytoextract and CBD Manufacturing Assets
The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The […]
Calixar Invests €1 Million in Pipeline of Highly Druggable Membrane Protein Targets and Native Antigens
Calixar, a biotechnology company with ten years expertise in the isolation of fully native membrane […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more